METABOLIC EFFECT OF A MINERALOCORTICOID RECEPTOR ANTAGONIST IN A NEW MODEL OF DIABETIC NEPHROPATHY

被引：0
|
作者：
Palacios, Roberto [1 ]
Bonnard, Benjamin [1 ]
Lima-Posada, Ixchel [1 ]
Genty, Marie [1 ]
Jaisser, Frederic [1 ]
机构：
[1] Sorbonne Univ, Cordeliers Res Ctr, INSERM, UMRS 1138, Paris, France
来源：
JOURNAL OF HYPERTENSION | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E33 / E33
页数：1
相关论文
共 50 条
  • [1] MINERALOCORTICOID RECEPTOR ANTAGONIST HAS BENEFICIAL RENAL EFFECTS IN A NEW MOUSE MODEL OF DIABETIC NEPHROPATHY
    Posada, Ixchel Lima
    Ramirez, Roberto Palacios
    Bonnard, Benjamin
    Genty, Marie
    Jaisser, Frederic
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 : E306 - E306
  • [2] The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
    Sato, Atsuhisa
    [J]. HYPERTENSION RESEARCH, 2015, 38 (06) : 367 - 374
  • [3] The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy
    Atsuhisa Sato
    [J]. Hypertension Research, 2015, 38 : 367 - 374
  • [4] Effect of an oral endothelin a receptor antagonist in a rat model of diabetic nephropathy.
    Harron, JC
    ORourke, D
    Gardiner, T
    Chakravarthy, U
    Upritchard, ACG
    Maxwell, AP
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2970 - A2970
  • [5] The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
    Goenka, Luxitaa
    Padmanaban, Raghavan
    George, Melvin
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2019, 14 (02): : 78 - 83
  • [6] Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
    Sun, Li-Jing
    Sun, Yan-Ni
    Shan, Jian-Ping
    Jiang, Geng-Ru
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (04) : 609 - 618
  • [7] Mineralocorticoid antagonist (spironolactone) ameliorates atherosclerosis and nephropathy in streptozotocin diabetic rats
    Okada, K
    Fujisawa, G
    Muto, S
    Fujita, N
    Itabashi, N
    Ishibashi, S
    [J]. CIRCULATION, 2002, 106 (19) : 115 - 115
  • [8] FINERENONE Mineralocorticoid receptor (MR) antagonist Treatment of chronic kidney disease/diabetic nephropathy Treatment of heart failure
    Cole, P.
    [J]. DRUGS OF THE FUTURE, 2015, 40 (12) : 801 - 808
  • [9] Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Diabetic Nephropathy Miniperspective
    Piotrowski, David W.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (18) : 7957 - 7966
  • [10] Impact of Mineralocorticoid Receptor Antagonism in a New Model of Diabetic Kidney Disease
    Ramirez, Roberto Palacios
    Posada, Ixchel Q. Lima
    Bonnard, Benjamin
    Genty, Marie
    Hartleib-Geschwindner, Judith
    Foufelle, Fabienne
    Bamberg, Krister
    Jaisser, Frederic
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 240 - 240
12345